Source: Virtual Congress 2020 – Paediatric asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Wang (Manchester (Greater Manchester), United Kingdom), L. Lowe (Manchester (Greater Manchester), United Kingdom), A. Simpson (Manchester (Greater Manchester), United Kingdom), C. Murray (Manchester (Greater Manchester), United Kingdom), S. Fowler (Manchester (Greater Manchester), United Kingdom). Clinically meaningful medium-term variability of fractional exhaled nitric oxide in a UK paediatric cohort. 683

Member's Comments

No comment yet.

Related content which might interest you: Same-day repeatability of fractional exhaled nitric oxide in severe asthma Source: Eur Respir J, 57 (5) 2003391; 10.1183/13993003.03391-2020 Year: 2021 The change in exhaled nitric oxide in adolescents – a longitudinal cohort study Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021 Clinical utility of fractional exhaled nitric oxide in severe asthma management Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019 Year: 2020 Is exhaled nitric oxide measurement useful in clinical practice? Source: ISSN=ISSN 1810-6838, ISBN=, page=185 Year: 2006 Long-term variation of exhaled nitric oxide Source: Eur Respir J 2005; 26: Suppl. 49, 736s Year: 2005 Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Exhaled nitric oxide measures using multiple flows in clinically relevant subgroups of COPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Predictors of exhaled nitric oxide (FENO) in a large population-based sample of schoolchildren Source: Eur Respir J 2007; 30: Suppl. 51, 724s Year: 2007 An eye to the future: exhaled nitric oxide as a predictor of clinical outcomes in asthma Source: Eur Respir J 2010; 35: 1200-1202 Year: 2010 Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children Source: Eur Respir J 2003; 21: 433-438 Year: 2003 Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients Source: Eur Respir J 2008; 31: 539-546 Year: 2008 Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review Source: Eur Respir J 2016; 47: 751-768 Year: 2016 Exhaled nitric oxide and its short- and long-term variation in health non-smoking subjects Source: Eur Respir J 2003; 22: Suppl. 45, 292s Year: 2003 Improvement of asthma control assessed by exhaled nitric oxide: a real-life longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005 Investigation on the effectiveness of the Mostgraph and fractional exhaled nitric oxide measurement in chronic cough Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Short-term repeatability of fractional exhaled nitric oxide (FENO) measurement in children Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing Year: 2016 Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019 Year: 2019 Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma? Source: Eur Respir J, 55 (5) 1901879; 10.1183/13993003.01879-2019 Year: 2020 The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients Source: Eur Respir J 2004; 24: Suppl. 48, 304s Year: 2004 Accuracy of exhaled nitric oxide to predict a loss of asthma control in well-controlled patients Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010